Massachusetts H4298 aims to phase out the use of certain phthalates in medical devices by 2035.

Massachusetts H4298, also known as An Act relative to toxic-free medical devices, seeks to reduce the use of harmful chemicals in medical devices. Specifically, it targets the use of Di(2-ethylhexyl) phthalate (DEHP) in intravenous solution containers and tubing. The bill mandates that starting January 1, 2030, manufacturers and sellers must notify customers and post notices by January 1, 2028, that they will not meet the deadline. By January 1, 2035, the sale and distribution of intravenous tubing made with intentionally added DEHP will be prohibited.

Massachusetts H4298 aims to phase out the use of certain phthalates in medical devices by 2035.

Massachusetts H4298, also known as An Act relative to toxic-free medical devices, seeks to reduce the use of harmful chemicals in medical devices. Specifically, it targets the use of Di(2-ethylhexyl) phthalate (DEHP) in intravenous solution containers and tubing. The bill mandates that starting January 1, 2030, manufacturers and sellers must notify customers and post notices by January 1, 2028, that they will not meet the deadline. By January 1, 2035, the sale and distribution of intravenous tubing made with intentionally added DEHP will be prohibited.